Single-gene testing by Sanger sequencing was considered as the most cost-effective method with low phenotypic and genetic heterogeneity. However, advances in NGS technology allows to study multiple targets with increased heterogeneity. IGnomix offer NGS panels for various diseases including life style (cardio vascular, diabetes and cancer etc.,) and genetic disorders.
- Identification of rare and common single-nucleotide variants (SNV’s), insertion and deletions
- De novo mutations
- High-quality data by deep sequencing